Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 8 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

13%

1 trials in Phase 3/4

Results Transparency

17%

1 of 6 completed trials have results

Key Signals

1 recruiting1 with results

Enrollment Performance

Analytics

N/A

3(60.0%)

Phase 1

1(20.0%)

Phase 3

1(20.0%)

5Total

N/A(3)

Phase 1(1)

Phase 3(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (8)

Showing 8 of 8 trials

NCT05254587Completed

Accuracy of IOLMASTER 700 Total Keratometry (TK)

Role: collaborator

NCT07261904Recruiting

BIOCHROMADERM® PMCF STUDY

Role: collaborator

NCT05636891Phase 1Completed

Pharmacokinetic/Pharmacodynamic Parameters of NNG-DEPO (Stimus) With Aranesp® (Amgen) in Treatment of Anemia in CKD Patients on Dialysis

Role: collaborator

NCT01860612Not ApplicableUnknown

Safety and Effectiveness of the CustomFlex Artificial Iris Prosthesis for the Treatment of Iris Defects

Role: lead

NCT04359498Completed

Retrospective Study of Surgical Complications in Patients With Defunctioning Stoma After Low Anterior Resection (LAR)

Role: collaborator

NCT03751033Not ApplicableCompleted

Influence of DisCoVisc Ophthalmic Viscosurgical Device (OVD) on Intraoperative Aberrometry Readings

Role: lead

NCT01028378Phase 3Completed

Safety and Efficacy Study of Topography-Guided LASIK to Treat Myopia and Hyperopia

Role: lead

NCT01978860Not ApplicableCompleted

A Prospective, First in Man Study to Evaluate the Safety and Performance of the NovaCross™ Micro-catheter

Role: collaborator

All 8 trials loaded